RS
Roivant Sciences Ltd.
ROIV· Health Care· BiotechnologyS&P 400
Close · 10/09/2026
40.94
1D
-2.08%52-week range
13.395 – 42.5
Volume
65,34,000.00
Price history
ROIV
11/08/2026 to 10/09/2026
O 41.27 H 41.41 L 40.22
1W+19.78%
1M+16.14%
3M+44.10%
6M+38.40%
1Y+203.71%
3Y+248.43%
5Y+311.46%
MAX+313.12%
Fundamentals
as of 10/09/2026- Market cap
- $29.57B
- Shares out
- 722.32M
- P/E (forward)
- -20.34
- EPS (trailing)
- -0.37
- Beta
- 1.12
- Profit margin
- -3534.96%
- P/B
- 6.99
- Return on equity
- -6.29%
SEC financial statements
19 quarterly and 6 annual periods through 30/06/2026.
Details
- Ticker
- ROIV
- Index
- SP400
- Sector
- Health Care
- Industry
- Biotechnology
- HQ
- -
Last close 10/09/2026.
Tracked by Congress
1 filer · 0 on watchlist · 2 buys · 2 sells · R: 4
- 31/10/2025Lisa McClainSellRoivant Sciences Ltd. - Common Shares$1,001–$15,000
- 30/10/2025Lisa McClainSellRoivant Sciences Ltd. - Common Shares$1,001–$15,000
- 30/10/2025Lisa McClainBuyRoivant Sciences Ltd. - Common Shares$1,001–$15,000
- 17/06/2025Lisa McClainBuyRoivant Sciences Ltd. - Common Shares$1,001–$15,000